tiprankstipranks
Collegium Pharmaceutical sees FY25 revenue $735M-$750M, consensus $739.84M
The Fly

Collegium Pharmaceutical sees FY25 revenue $735M-$750M, consensus $739.84M

Sees FY25: Adjusted EBITDA is expected in the range of $435 million to $450 million. Adjusted operating expenses are expected in the range of $220 million to $230 million.

Stay Ahead of the Market:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App